Latest & greatest articles for screening

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on screening or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on screening and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for screening

3361. [Should hepatitis C be screened: socioeconomic analysis of various screening strategies for chronic hepatitis C in a French population]

[Should hepatitis C be screened: socioeconomic analysis of various screening strategies for chronic hepatitis C in a French population] Faut-il depister l'hepatite C: analyse socioeconomique de differentes strategies de depistage de l'hepatite chronique C dans la population francaise [Should hepatitis C be screened: socioeconomic analysis of various screening strategies for chronic hepatitis C in a French population] Faut-il depister l'hepatite C: analyse socioeconomique de differentes (...) strategies de depistage de l'hepatite chronique C dans la population francaise [Should hepatitis C be screened: socioeconomic analysis of various screening strategies for chronic hepatitis C in a French population] Rotily M, Loubiere S, Nixon J, Bourliere M, Halfon P, Moatti J P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed

1997 NHS Economic Evaluation Database.

3362. Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with alpha-fetoprotein and its glycoforms

Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with alpha-fetoprotein and its glycoforms Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with alpha-fetoprotein and its glycoforms Mass screening for early detection of hepatocellular carcinoma by setting a high-risk population with alpha-fetoprotein and its glycoforms Rimal N, Ikeda S, Taketa K, Kariya T Record Status This is a critical abstract (...) of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Mass screening programme for detecting hepatocellular carcinoma (HCC). Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Elderly Japanese people attending a periodic mass screening

1997 NHS Economic Evaluation Database.

3363. Cost implications of selective preoperative risk screening in the care of candidates for peripheral-vascular operations

Cost implications of selective preoperative risk screening in the care of candidates for peripheral-vascular operations Cost implications of selective preoperative risk screening in the care of candidates for peripheral-vascular operations Cost implications of selective preoperative risk screening in the care of candidates for peripheral-vascular operations Shaw L J, Hachamovitch R, Cohen M, Berman D S, Borges-Neto S, Udelson J E, Heller G V, Eisenstein E L, Eagle K A, Hendel R C, Miller D D (...) Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Preoperative screening of patients undergoing peripheral vascular operations. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Patients

1997 NHS Economic Evaluation Database.

3364. Diagnosis, management and screening of early localised prostate cancer

Diagnosis, management and screening of early localised prostate cancer Diagnosis, management and screening of early localised prostate cancer Diagnosis, management and screening of early localised prostate cancer Selley S, Donovan J, Faulkner A, Coast J, Gillatt D Authors' objectives To assess the clinical and cost-effectiveness of methods for the diagnosis, treatment and screening of early localised prostate cancer. Searching EMBASE, Cancerlit, MEDLINE, the Social Sciences Citation Index (...) . The interventions addressed in the review were as follows. Diagnosis or screening: digital rectal examination (DRE), prostate- specific antigen (PSA), transrectal ultrasound imaging (TRUS) and needle biopsy. The tests were assessed both alone and in combination, e.g. DRE plus PSA. Treatment: radical prostatectomy, radiotherapy and conservative management. Reference standard test against which the new test was compared No inclusion criteria relating to the reference standard were specified for the diagnostic

1997 DARE.

3365. Newborn screening for inborn errors of metabolism: a systematic review

Newborn screening for inborn errors of metabolism: a systematic review Newborn screening for inborn errors of metabolism: a systematic review Newborn screening for inborn errors of metabolism: a systematic review Seymour C A, Thomason M J, Chalmers R A, Addison G M, Bain M D, Cockburn F, Littlejohns P, Lord J, Wilcox A H Authors' objectives The authors' stated objectives were: to undertake a systematic review of the data as a basis for the evaluation of newborn screening for inborn errors (...) of metabolism; to prepare an objective summary of the evidence on the appropriateness and need for various existing and possible neonatal screening programmes for inborn errors of metabolism in relation to the natural history of these diseases; to identify gaps in existing knowledge and make recommendations for required primary research; and to make recommendations for the future development and organisation of neonatal screening. Searching MEDLINE was searched from 1966 to June 1996 for publications in any

1997 DARE.

3366. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment

A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment Davis A, Bamford J, Wilson I, Ramkalawan T, Forshaw M, Wright S Authors' objectives To assess the role of neonatal hearing screening in the detection of congenital (...) hearing impairment. The authors also collected information on how to deliver a more uniform service, better outcomes and more cost effective screening, and identified areas for further research and development. Searching The authors searched the electronic databases of BIDS, EMBASE, ISSI and ISI, ERIC, PsycLIT, MEDLINE, CINAHL, the British Library catalogue and thesis listings (dates not specified) using a list of keywords developed by expert members of the review team. Searches of the internet

1997 DARE.

3367. Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age

Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Cost-effectiveness of extending screening mammography guidelines to include women 40 to 49 years of age Salzmann P, Kerlikowske K, Phillips K Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening mammography for women 40-49 years. Type of intervention Screening. Economic study type Cost-effectiveness and cost-utility analysis. Study population Women of 40 years of age and older. Setting Primary care. The study was carried out in California, USA. Dates to which data relate The effectiveness data were obtained from

1997 NHS Economic Evaluation Database.

3368. Screening for major deep vein thrombosis in seriously injured patients: a prospective study

Screening for major deep vein thrombosis in seriously injured patients: a prospective study Screening for major deep vein thrombosis in seriously injured patients: a prospective study Screening for major deep vein thrombosis in seriously injured patients: a prospective study Satiani B, Falcone R, Shook L, Price J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results (...) and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Venous duplex scanning (VDS) for major deep vein thrombosis (DVT) in seriously injured trauma patients receiving prophylaxis with a sequential compression device (SCD) or low-dose subcutaneous heparin (SH) to decrease the incidence of DVT and pulmonary embolism. VDS was performed on inpatients on days 2-5, day 11 and day 30 following admission. Type of intervention Screening

1997 NHS Economic Evaluation Database.

3369. Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening

Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening Effectiveness and cost of rapid and conventional laboratory methods for Mycobacterium tuberculosis screening Heymann S J, Brewer T F, Ettling M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) to adequate treatment in countries with low rates of both M. tuberculosis and multiple drug resistance. Authors' conclusions Rapid diagnostic tests increase sensitivity and reduce the time to diagnosis. This leads to earlier therapy and reduction in complications and costs. CRD COMMENTARY - Selection of comparators The comparators have been correctly identified as the conventional diagnostic methods for TB screening. Validity of estimate of measure of benefit A sensitivity analysis was performed

1997 NHS Economic Evaluation Database.

3370. HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicity

HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicity HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicity HLA antibody screening: comparison of a solid phase enzyme-linked immunoassay with antiglobulin-augmented lymphocytotoxicity Moore S B, Ploeger N A, DeGoey S R Record Status This is a critical abstract of an economic evaluation that meets (...) the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Using a solid phase enzyme-linked method (EIA) as a prescreen or antihuman globulin-augmented lymphocytotoxicity(AHG-CDC) for regular determination of HLA class I alloimmunization. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study

1997 NHS Economic Evaluation Database.

3371. Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis

Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pulmonary recurrences: a cost-effectiveness analysis Mooney M M, Mettlin C, Michalek A M, Petrelli N J (...) , Kraybill W G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Life-long screening of patients with intermediate thickness cutaneous melanoma for asymptomatic pulmonary recurrences. Type of intervention Primary prevention. Economic

1997 NHS Economic Evaluation Database.

3372. Screening pulmonary tuberculosis suspects in Malawi: testing different strategies

Screening pulmonary tuberculosis suspects in Malawi: testing different strategies Screening pulmonary tuberculosis suspects in Malawi: testing different strategies Screening pulmonary tuberculosis suspects in Malawi: testing different strategies Harries A D, Kamenya A, Subramanyam V R, Maher D, Squire S B, Wirima J J, Nyangulu D S, Nunn P Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening pulmonary tuberculosis (PTB) suspects using two hypothetical strategies: (1) screen by sputum smear then chest X-ray (CXR) on smear negative patients, or (2) screen by chest radiograph then sputum smear on patients with CXR consistent with tuberculosis (TB). Type of intervention Screening. Economic study type Cost-effectiveness analysis

1997 NHS Economic Evaluation Database.

3373. Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation

Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation Is it cost effective to introduce screening programmes for colorectal cancer? Illustrating the principles of optimal resource allocation Gyrd-Hansen D Record Status This is a critical abstract of an economic evaluation (...) that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The Hemoccult test-II for the detection of colorectal cancer was compared to the use of the Pap smear test for the detection of cervical cancer. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Inhabitants

1997 NHS Economic Evaluation Database.

3374. Cost-effectiveness of screening for carotid stenosis in asymptomatic persons

Cost-effectiveness of screening for carotid stenosis in asymptomatic persons Cost-effectiveness of screening for carotid stenosis in asymptomatic persons Cost-effectiveness of screening for carotid stenosis in asymptomatic persons Lee T L, Solomon N A, Heidenreich P A, Oehlert J, Garber A M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions (...) followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology Screening for carotid stenosis using duplex Doppler ultrasonography before carotid endarterectomy in asymptomatic patients. Type of intervention Screening. Economic study type Cost-utility analysis. Study population Asymptomatic sixty-five-year-old men without neurologic symptoms of carotid stenosis such as transient ischemic attack, reversible ischemic neurologic deficit, amaurosis

1997 NHS Economic Evaluation Database.

3375. Future benefits and cost-effectiveness of prostate carcinoma screening

Future benefits and cost-effectiveness of prostate carcinoma screening Future benefits and cost-effectiveness of prostate carcinoma screening Future benefits and cost-effectiveness of prostate carcinoma screening Littrup P J Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability (...) of the study and the conclusions drawn. Health technology Screening for prostate carcinoma. Type of intervention Screening. Economic study type Cost-utility analysis. Study population Men aged 45-70 and over 70 years diagnosed with prostate carcinoma. Setting Hospital/community. The study was carried out in the USA. Dates to which data relate Data on incidence trends related to age groups and racial differences were gathered between 1973 and 1994. The studies included in the review covered the period 1993

1997 NHS Economic Evaluation Database.

3376. Economic evaluation of a mammography-based breast cancer screening programme in Spain

Economic evaluation of a mammography-based breast cancer screening programme in Spain Economic evaluation of a mammography-based breast cancer screening programme in Spain Economic evaluation of a mammography-based breast cancer screening programme in Spain Garuz R, Forcen T, Cabases J, Antonanzas F, Trinxet C, Rovira J, Anton F Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary (...) of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology A mammography-based breast cancer screening programme. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population The study population comprised women between 50 and 65 years of age. Setting Secondary care. The study was carried out in Spain. Dates to which data relate The data for the effectiveness

1997 NHS Economic Evaluation Database.

3377. Perimenopausal bone density screening: will it help prevent osteoporosis?

Perimenopausal bone density screening: will it help prevent osteoporosis? Perimenopausal bone density screening: will it help prevent osteoporosis? Perimenopausal bone density screening: will it help prevent osteoporosis? Garton M J, Cooper C, Reid D Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Bone mineral density (BMD) screening by measurement at femoral neck and lumbar spine using energy X-ray absorptiometry (DXA) and in the distal radial trabecular bone using peripheral quantitative computed tomography (pqTC). Selective hormone replacement therapy (HRT) using Prempac C 0.625 mg daily (if uterus intact) and Premarin alone (if hysterectomy) in the prevention of osteoporotic fractures. Type of intervention Screening; primary

1997 NHS Economic Evaluation Database.

3378. Cost-effectiveness analysis of prostatic cancer screening

Cost-effectiveness analysis of prostatic cancer screening Cost-effectiveness analysis of prostatic cancer screening Cost-effectiveness analysis of prostatic cancer screening Nakagawa S, Ebisui K, Sugimoto K, Nakanishi H, Kanemitsu N, Watanabe H Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment (...) on the reliability of the study and the conclusions drawn. Health technology Standard tests in the screening of prostatic cancer (PC). Type of intervention Screening. Economic study type Cost-effective analysis. Study population A hypothetical cohort of 10,000 asymptomatic males for which estimations for PC screening were conducted for three age groups: 55-59, 60-69 and 70-79 years old. Setting Hospitals and clinics in Japan. Dates to which data relate The detection rate of PC, sensitivity and specificity of PC

1997 NHS Economic Evaluation Database.

3379. Dipstick only urinalysis screen for the pediatric emergency room

Dipstick only urinalysis screen for the pediatric emergency room Dipstick only urinalysis screen for the pediatric emergency room Dipstick only urinalysis screen for the pediatric emergency room Craver R D, Abermanis J G Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study (...) and the conclusions drawn. Health technology Dipstick urinalysis screening test in the diagnosis of urinary tract infections (UTI). Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Children suspected of having urinary tract infections (UTI). Setting Hospital. The economic analysis was conducted in the USA. Dates to which data relate Neither the year in which the effectiveness data were gathered nor the year of pricing were reported. Source of effectiveness data

1997 NHS Economic Evaluation Database.

3380. Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis: the EATHIS Eco Research GrouEuropean Acute Transfusion Hepatitis Interferon Study

Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis: the EATHIS Eco Research GrouEuropean Acute Transfusion Hepatitis Interferon Study Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis: the EATHIS Eco Research GrouEuropean Acute Transfusion Hepatitis Interferon Study Cost-effectiveness of screening blood donors for hepatitis C and non-A, non-B, non-C hepatitis: the EATHIS Eco Research GrouEuropean Acute (...) to hepatitis B core antigen (anti-HBc)) versus a three-test approach (ALT, anti-HBc, and testing for anti-hepatitis C virus antibodies (anti-HCV) through enzyme immunoassay (EIA)) in screening blood donors in order to discard infected donations. Type of intervention Screening. Economic study type Cost-effectiveness analysis. Study population Blood donors. Setting Tertiary care (blood transfusion centres). The economic study was carried out in France. Dates to which data relate The data related

1997 NHS Economic Evaluation Database.